54. Koniar, H., Wharton, L., Ingham, A., Rodríguez-Rodríguez, C., Kunz, P., Radchenko, V., Yang, H., Rahmim, A., Uribe, C., & Schaffer, P. (2024). In vivo quantitative SPECT imaging of actinium-226: feasibility and proof-of-concept. Physics in Medicine & Biology, 69(15), 155003. https://doi.org/10.1088/1361-6560/ad5c37
53. Koniar, H., McNeil, S., Wharton, L., Ingham, A., Van de Voorde, M., Ooms, M., Sekar, S., Rodríguez-Rodríguez, C., Kunz, P., Radchenko, V., Rahmim, A., Uribe, C., Yang, H., & Schaffer, P. (2024). Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development. EJNMMI Physics, 11, Article 77. https://doi.org/10.1186/s40658-024-00477-4
51. Wharton, L., McNeil, S.W., Zhang, C., Engudar, G., Van de Voorde, M., Zeisler, J., Koniar, H., Sekar, S., Yuan, Z., Schaffer, P., Radchenko, V., Ooms, M., Kunz, P., Bénard, F., & Yang, H. (2024). Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH. Nuclear Medicine and Biology, 136–137, 108925. https://doi.org/10.1016/j.nucmedbio.2024.108925
50. Nosrati, Z., Chen, Y. A., Bergamo, M., Rodríguez-Rodríguez, C., Chan, J., Shojania, K., Kherani, R. B., Chin, C., Kelsall, J. T., Dehghan, N., Colwill, A. M., Collins, D., Saatchi, K., & Häfeli, U. O. (2024). Prodrug Nanomedicine for Synovium Targeted Therapy of Inflammatory Arthritis: Insights from Animal Model and Human Synovial Joint Fluid. Advanced Healthcare Materials, 2024, 2401936 https://doi.org/10.1002/adhm.202401936
49. Esposito TVF, Rodriguez-Rodriguez C, Blackadar C, Kłodzińska S, Mørck Nielsen H., Saatchi K, Hafeli UO (2024). Biodistribution of the cationic host defense peptide LL-37 using SPECT/CT. European Journal of Pharmaceutics and Biopharmaceutics, 114398
48. Esposito TVF, Blackadar C, Wu L, Rodriguez-Rodriguez C, Haney EF, Pletzer D, Saatchi K, Hancock REW, Hafeli UO (2024). Biodistribution of native and nano-formulated Innate Defense Regulator (IDR) peptide 1002. Mol Pharm, 21, 2751-2766
47. Bohrmann L, Poulie CBM, Rodríguez-Rodríguez C, Karagiozov S, Saatchi K, Herth MM, et al. (2024) Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model. PLoS ONE 19(4), e0300466
46. Wu J, Jones N, Chao PH, Chan V, Hohenwarter L, Wu A, Bergamo M, Rodríguez-Rodríguez C, Saatchi K, Liang A, Häfeli UO, Tan Z, Hedtrich S, Andrew LJ, Li SD (2024). Intranasal delivery of low-dose anti-CD124 antibody enhances the treatment of chronic rhinosinusitis with nasal polyps. Biomaterials 308, 122567
45. Hohenwarter L, Puil E, Rouhollahi E, Bohrmann L, Lu S, Saatchi K, Häfeli UO, Barr A, Bottger R, DurgaRao Viswanadham KK, Li SD (2024). A Novel Leu-Enkephalin Prodrug Produces Pain-Relieving and Antidepressant Effects. Mol Pharm 21 (2), 688-703
44. Charles L, Sekar S, Osooly M, Javed S, Williams KC, Welch I, Barta I, Saatchi K, Häfeli UO (2024). Development of an Immunosuppressed Orthotopic Hepatocellular Carcinoma Rat Model for the Evaluation of Chemo- and Radioembolization Therapies. Europ J Pharm Biopharm 196, 114180